SOURCE: Medpace


September 23, 2014 07:00 ET

Medpace Salutes Julie J. Hopkins, Cincinnati Leukemia & Lymphoma Society Woman of the Year 2014

CINCINNATI, OH--(Marketwired - Sep 23, 2014) -  Medpace, Inc. salutes Medpace's Julie J. Hopkins as the 2014 Cincinnati Leukemia and Lymphoma Woman of the Year. Ms. Hopkins, a Medpace marketing executive, was instrumental in channeling her business and social network to raise nearly $115,000 in 10 short weeks, earning the Woman of the Year honor.

Each year, in communities across the country, dynamic, passionate candidates engage in a spirited competition to earn The Leukemia & Lymphoma Society's "Man & Woman of the Year" titles by raising funds for blood cancer research. The candidates compete in honor of children who are local blood cancer survivors, the Boy & Girl of the Year. Every dollar counts as one vote, and the titles are awarded to the man and woman with the most votes at the end of ten weeks. The top local fundraisers in the country win the national titles. To date, these dedicated leaders have helped LLS invest almost $1 billion in research to advance breakthrough therapies that are saving lives today.

Medpace, a clinical research organization (CRO) has a mission to develop therapies to fight cancer in conjunction with the biopharmaceutical community. Oncology research is one of the leading therapeutic areas for Medpace and supporting Medpace employees in these endeavors represents a key activity to find a cure for blood cancers.

Woman of the Year, Julie Hopkins of Medpace was part of a group of 13 participants that collectively raised almost $550,000 for cancer research and patient access. The 10 week campaign concluded on May 30th at the Hilton Netherland Plaza.

Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across a number of therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and orphan disease. With extensive medical expertise, and renowned regulatory affairs department, Medpace employs 2000 employees and has clinical trial experience in over 45 countries and 6 regions -- the US, Europe, Central and Eastern Europe, India, Asia Pacific, and China. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. In addition, Medpace offers integrated imaging, central and bioanalytical lab capabilities, and clinical pharmacology through wholly-owned business units to provide cohesive, streamlined, and standardized trial management.

For more information visit the Medpace website at: